S&P 500   4,512.96 (+0.59%)
DOW   35,418.41 (+0.45%)
QQQ   374.61 (+0.53%)
AAPL   148.60 (+1.40%)
MSFT   308.18 (+0.29%)
FB   339.05 (+1.11%)
GOOGL   2,855.67 (+0.00%)
TSLA   871.05 (+0.11%)
AMZN   3,434.40 (-0.36%)
NVDA   221.74 (-0.22%)
BABA   173.79 (+4.18%)
NIO   39.93 (+0.81%)
CGC   13.46 (+1.97%)
GE   104.77 (+0.62%)
AMD   116.17 (-0.22%)
MU   67.03 (-0.34%)
T   25.43 (+0.39%)
F   15.55 (-0.06%)
ACB   6.98 (+0.87%)
DIS   170.34 (-0.47%)
PFE   42.14 (+1.98%)
BA   216.55 (-0.20%)
AMC   42.59 (-1.02%)
S&P 500   4,512.96 (+0.59%)
DOW   35,418.41 (+0.45%)
QQQ   374.61 (+0.53%)
AAPL   148.60 (+1.40%)
MSFT   308.18 (+0.29%)
FB   339.05 (+1.11%)
GOOGL   2,855.67 (+0.00%)
TSLA   871.05 (+0.11%)
AMZN   3,434.40 (-0.36%)
NVDA   221.74 (-0.22%)
BABA   173.79 (+4.18%)
NIO   39.93 (+0.81%)
CGC   13.46 (+1.97%)
GE   104.77 (+0.62%)
AMD   116.17 (-0.22%)
MU   67.03 (-0.34%)
T   25.43 (+0.39%)
F   15.55 (-0.06%)
ACB   6.98 (+0.87%)
DIS   170.34 (-0.47%)
PFE   42.14 (+1.98%)
BA   216.55 (-0.20%)
AMC   42.59 (-1.02%)
S&P 500   4,512.96 (+0.59%)
DOW   35,418.41 (+0.45%)
QQQ   374.61 (+0.53%)
AAPL   148.60 (+1.40%)
MSFT   308.18 (+0.29%)
FB   339.05 (+1.11%)
GOOGL   2,855.67 (+0.00%)
TSLA   871.05 (+0.11%)
AMZN   3,434.40 (-0.36%)
NVDA   221.74 (-0.22%)
BABA   173.79 (+4.18%)
NIO   39.93 (+0.81%)
CGC   13.46 (+1.97%)
GE   104.77 (+0.62%)
AMD   116.17 (-0.22%)
MU   67.03 (-0.34%)
T   25.43 (+0.39%)
F   15.55 (-0.06%)
ACB   6.98 (+0.87%)
DIS   170.34 (-0.47%)
PFE   42.14 (+1.98%)
BA   216.55 (-0.20%)
AMC   42.59 (-1.02%)
S&P 500   4,512.96 (+0.59%)
DOW   35,418.41 (+0.45%)
QQQ   374.61 (+0.53%)
AAPL   148.60 (+1.40%)
MSFT   308.18 (+0.29%)
FB   339.05 (+1.11%)
GOOGL   2,855.67 (+0.00%)
TSLA   871.05 (+0.11%)
AMZN   3,434.40 (-0.36%)
NVDA   221.74 (-0.22%)
BABA   173.79 (+4.18%)
NIO   39.93 (+0.81%)
CGC   13.46 (+1.97%)
GE   104.77 (+0.62%)
AMD   116.17 (-0.22%)
MU   67.03 (-0.34%)
T   25.43 (+0.39%)
F   15.55 (-0.06%)
ACB   6.98 (+0.87%)
DIS   170.34 (-0.47%)
PFE   42.14 (+1.98%)
BA   216.55 (-0.20%)
AMC   42.59 (-1.02%)
NYSE:DGX

Quest Diagnostics News Headlines

$145.80
+2.08 (+1.45 %)
(As of 10/19/2021 11:27 AM ET)
Add
Compare
Today's Range
$144.50
$146.20
50-Day Range
$140.36
$158.00
52-Week Range
$113.36
$160.56
Volume13,149 shs
Average Volume1.24 million shs
Market Capitalization$17.81 billion
P/E Ratio8.69
Dividend Yield1.74%
Beta1.04

Media Mentions By Week

Quest Diagnostics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DGX
News Sentiment

0.29

0.36

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DGX Articles
This Week

20

4

DGX Articles
Average Week

Get Quest Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter.

Quest Diagnostics (NYSE DGX) News Headlines Today

SourceHeadline
marketbeat.com logoInvestors Are Getting a Gift With the Dip in Dollar General
marketbeat.com - August 26 at 1:00 PM
benzinga.com logoPrice Over Earnings Overview: Quest Diagnostics
benzinga.com - October 19 at 11:20 AM
finance.yahoo.com logoHedge Funds Are Dumping Quest Diagnostics Incorporated (DGX)
finance.yahoo.com - October 18 at 1:42 PM
finance.yahoo.com logoCommunities of Color Hit Hardest by COVID-19 and Lack Trust in Healthcare
finance.yahoo.com - October 18 at 1:42 PM
markets.businessinsider.com logoQuest To Introduce Companion Diagnostic Ki-67 IHC MIB-1 PharmDx In High-Risk Early Breast Cancer
markets.businessinsider.com - October 18 at 8:14 AM
finance.yahoo.com logoDA Authorizes Quest Diagnostics' COVID-19 Collection Materials for Emergency Use
finance.yahoo.com - October 15 at 11:54 AM
nasdaq.com logoDGX December 17th Options Begin Trading
nasdaq.com - October 14 at 6:35 PM
finance.yahoo.com logoQuest Diagnostics (DGX) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - October 14 at 6:35 PM
msn.com logoCOVID Test Demand to Aid Quest Diagnostics (DGX) Q3 Earnings
msn.com - October 14 at 8:34 AM
finance.yahoo.com logoGive it a Shot: The Latest on the Flu & COVID Vaccine
finance.yahoo.com - October 13 at 7:50 PM
finance.yahoo.com logoQuotient Limited Announces Appointment of Chief Financial Officer
finance.yahoo.com - October 12 at 8:51 AM
finance.yahoo.com logoQuest Diagnostics Debuts Next-Generation Lab Facility in Clifton, NJ
finance.yahoo.com - October 12 at 8:51 AM
finance.yahoo.com logoAre Investors Undervaluing Quest Diagnostics (DGX) Right Now?
finance.yahoo.com - October 8 at 3:15 PM
finance.yahoo.com logoReducing Health Inequities While Expanding the Pipeline to Create a More Diverse Health Care Workforce
finance.yahoo.com - October 8 at 10:15 AM
finance.yahoo.com logoAddressing the Healthcare Needs of Underserved Communities
finance.yahoo.com - October 7 at 12:29 PM
finance.yahoo.com logoDown 9.4% in 4 Weeks, Here's Why Quest Diagnostics (DGX) Looks Ripe for a Turnaround
finance.yahoo.com - October 5 at 1:12 PM
finance.yahoo.com logoThere's A Lot To Like About Quest Diagnostics' (NYSE:DGX) Upcoming US$0.62 Dividend
finance.yahoo.com - October 1 at 8:27 AM
finance.yahoo.com logoQuest Diagnostics To Release Third Quarter 2021 Financial Results On October 21
finance.yahoo.com - September 29 at 7:43 PM
baystreet.ca logoFalse Positives Scare Highlights Need for Changes to Covid-19 Testing Processes
baystreet.ca - September 28 at 11:34 PM
finance.yahoo.com logoEngaging Student Journalists to Promote Health Awareness
finance.yahoo.com - September 28 at 11:34 PM
finance.yahoo.com logoBlack and Hispanic Communities Are Lagging in Getting Vaccinated. How These Organizations Are Trying to Change That
finance.yahoo.com - September 23 at 2:36 PM
finance.yahoo.com logoBet on These 3 MedTech Growth Stocks for 2021 & Beyond
finance.yahoo.com - September 22 at 2:06 PM
finance.yahoo.com logoWhy Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
finance.yahoo.com - September 22 at 2:06 PM
finance.yahoo.com logoQuest Diagnostics' (DGX) COVID-19 Test Demand Up in Q3 Months
finance.yahoo.com - September 20 at 1:27 PM
nasdaq.com logoThere Is A Reason Quest Diagnostics Incorporated's (NYSE:DGX) Price Is Undemanding
nasdaq.com - September 19 at 3:08 PM
finance.yahoo.com logoInstead of Buying Dogecoin, Invest in These 3 Companies That Are Bullish on Blockchain Technology
finance.yahoo.com - September 16 at 7:56 AM
finance.yahoo.com logoHere's Why I Think Quest Diagnostics (NYSE:DGX) Is An Interesting Stock
finance.yahoo.com - September 14 at 9:47 AM
finance.yahoo.com logoQuest Diagnostic (DGX) Raises View on COVID-19 Testing Surge
finance.yahoo.com - September 10 at 3:34 PM
nasdaq.com logoQuest Diagnostics raises 2021 profit outlook on uptick in COVID-19 testing
nasdaq.com - September 9 at 4:00 PM
finance.yahoo.com logoQuest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests
finance.yahoo.com - September 9 at 4:00 PM
nasdaq.com logoQuest Diagnostics Raises 2021 Guidance - Quick Facts
nasdaq.com - September 9 at 9:39 AM
finance.yahoo.com logoQuest Diagnostics Updates Outlook For Full Year 2021
finance.yahoo.com - September 9 at 9:39 AM
finance.yahoo.com logoQuest Diagnostics hikes financial estimates on Delta variant testing boost
finance.yahoo.com - September 9 at 9:39 AM
finance.yahoo.com logoCovid Testing Companies Rake in Big Bucks From Big Delta Numbers
finance.yahoo.com - September 2 at 11:08 PM
finance.yahoo.com logoQuest Diagnostics Shows Rising Price Performance With Jump To 82 RS Rating
finance.yahoo.com - September 1 at 4:43 PM
finance.yahoo.com logoCancer Diagnoses Declined Sharply During First Year of COVID-19 Pandemic, Finds Quest Diagnostics Health Trends® Study Published in JAMA Network Open
finance.yahoo.com - August 31 at 12:46 PM
finance.yahoo.com logoQuest Diagnostics to Speak at the Morgan Stanley 19th Annual Global Healthcare Conference
finance.yahoo.com - August 30 at 3:32 PM
nasdaq.com logoInvestors in Quest Diagnostics (NYSE:DGX) have made a notable return of 99% over the past five years
nasdaq.com - August 30 at 9:43 AM
finance.yahoo.com logoQuest Diagnostics (DGX) Acquires Florida-Based NLS Assets
finance.yahoo.com - August 25 at 3:40 PM
seekingalpha.com logoQuest Diagnostics: Too Richly Valued Based On Current Upside
seekingalpha.com - August 25 at 7:29 AM
finance.yahoo.com logoWhat Is Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Doing?
finance.yahoo.com - August 19 at 5:37 PM
finance.yahoo.com logoShould You Consider Investing in Quest Diagnostics (DGX)?
finance.yahoo.com - August 18 at 3:48 PM
finance.yahoo.com logoApple to Increase Covid Testing of Staff as Delta Spreads
finance.yahoo.com - August 17 at 3:47 PM
finance.yahoo.com logoQuest Diagnostics Elects Tracey C. Doi to Board of Directors
finance.yahoo.com - August 17 at 9:18 AM
baystreet.ca logoVaccine Passports and Validation are Essential with Global Pandemic Cases Surging Again
baystreet.ca - August 12 at 4:28 PM
finance.yahoo.com logoQuest Diagnostics (DGX) Hits a 52-Week High: What's Driving It?
finance.yahoo.com - August 11 at 12:14 PM
nasdaq.com logoInvestors Shouldn't Overlook Quest Diagnostics' (NYSE:DGX) Impressive Returns On Capital
nasdaq.com - August 10 at 10:37 AM
fool.com logo3 Medical Diagnostic Stocks That Look Like Great Buys Right Now
fool.com - August 7 at 7:25 AM
finance.yahoo.com logoColumn: Lose your health coverage? Don't hesitate to haggle with medical providers
finance.yahoo.com - August 6 at 9:37 AM
uk.finance.yahoo.com logoQuest Diagnostics Inc (DGX) Chairman, CEO and President Stephen H Rusckowski Sold $20.
uk.finance.yahoo.com - July 31 at 12:51 AM
fool.com logoIs This Diagnostics Company a Buy After Blowing Away Earnings Estimates?
fool.com - July 30 at 7:28 AM
Get Quest Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.